12:00 AM
 | 
Mar 18, 2013
 |  BC Week In Review  |  Company News  |  Other News

Prokarium, Biotechnology and Biological Science Research Council, U.K. Technology Strategy Board (TSB), University of Birmingham infectious news

Prokarium and the university's Institute of Microbiology and Infection were awarded a £400,000 ($597,320) grant from the TSB and the BBSRC to fund the development of Prokarium's Vaxonella oral vaccine delivery technology as well as two vaccine candidates. The grant...

Read the full 178 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >